Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN) Social Stream
BIOHAVEN LTD (BHVN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BHVN.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-10 | 11 | $165 | $109 | $148.6 | $45.46 | 226.88% |
2022-01-04 | 10 | $177 | $109 | $150 | $45.46 | 229.96% |
2022-01-07 | 10 | $177 | $109 | $150.8 | $45.46 | 231.72% |
2022-02-03 | 10 | $177 | $109 | $152.2 | $45.46 | 234.8% |
2022-02-28 | 10 | $177 | $109 | $151.7 | $45.46 | 233.7% |
2022-03-01 | 10 | $182 | $109 | $152.2 | $45.46 | 234.8% |
2022-04-26 | 10 | $182 | $109 | $152 | $45.46 | 234.36% |
2022-04-28 | 9 | $182 | $109 | $151.1 | $45.46 | 232.38% |
2022-05-10 | 9 | $182 | $109 | $151.35 | $45.46 | 232.93% |
2022-05-11 | 9 | $170 | $109 | $148.2 | $45.46 | 226% |
2022-05-24 | 9 | $165 | $109 | $145.8 | $45.46 | 220.72% |
2022-06-21 | 9 | $165 | $109 | $147.15 | $45.46 | 223.69% |
2022-08-08 | 9 | $165 | $109 | $146.833 | $45.46 | 222.99% |
2022-08-19 | 6 | $165 | $144 | $152.333 | $45.46 | 235.09% |
2022-10-12 | 5 | $165 | $23 | $127.9 | $45.46 | 181.35% |
2022-10-26 | 5 | $165 | $21 | $101.1 | $45.46 | 122.39% |
2022-11-10 | 5 | $148.5 | $21 | $55.375 | $45.46 | 21.81% |
2023-01-04 | 5 | $27 | $21 | $24 | $45.46 | -47.21% |
2023-03-24 | 6 | $27 | $21 | $24 | $45.46 | -47.21% |
2023-04-20 | 6 | $31 | $21 | $24.75 | $45.46 | -45.56% |
2023-04-24 | 6 | $31 | $21 | $24.8 | $45.46 | -45.45% |
2023-05-16 | 6 | $31 | $20 | $24.2 | $45.46 | -46.77% |
2023-05-17 | 6 | $31 | $21 | $24.4 | $45.46 | -46.33% |
2023-06-01 | 7 | $31 | $21 | $25.2 | $45.46 | -44.57% |
2023-06-06 | 7 | $31 | $21 | $25 | $45.46 | -45.01% |
2023-08-01 | 7 | $31 | $21 | $26.4 | $45.46 | -41.93% |
2023-08-16 | 7 | $31 | $23 | $26.4 | $45.46 | -41.93% |
2023-10-06 | 7 | $31 | $23 | $26.8 | $45.46 | -41.05% |
2023-10-08 | 7 | $31 | $25 | $27.8 | $45.46 | -38.85% |
2023-11-16 | 7 | $36 | $26 | $31.8 | $45.46 | -30.05% |
2023-11-20 | 8 | $37 | $31 | $33.666 | $45.46 | -25.94% |
2023-12-08 | 9 | $58 | $31 | $37.142 | $45.46 | -18.3% |
2023-12-22 | 9 | $58 | $31 | $38.75 | $45.46 | -14.76% |
The Trend in the Analyst Price Target
BHVN's average price target has moved up $13.95 over the prior 35 weeks.
BHVN reports an average of 37.09% for its upside potential over the past 47 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-01-24 | 6 | 27 | 21 | 24.000 | 18.73 | 28.14% |
2023-03-23 | 6 | 27 | 21 | 24.000 | 13.40 | 79.1% |
2023-04-25 | 6 | 31 | 20 | 24.200 | 13.41 | 80.46% |
2023-06-16 | 7 | 31 | 21 | 26.400 | 23.65 | 11.63% |
2023-12-08 | 9 | 58 | 31 | 37.142 | 33.06 | 12.35% |
BHVN Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 9 | 0 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
BHVN's average broker recommendation rating improved by 0.36 over the prior 44 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how BIOHAVEN LTD fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2304.52% of that group.
- In terms of how BIOHAVEN LTD fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 3249.16% of that group.
- BHVN has a lower variance in analysts' estimates than -1350.83% of Pharmaceutical Products stocks.
- In the context of stocks in the mid market cap category, BIOHAVEN LTD's number of analysts covering the stock is higher than 2275.34% of them.
In the Pharmaceutical Products industry, GPCR, PASG, and BDTX are the three stocks most similar to BIOHAVEN LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BHVN a Buy, Hold or Sell? See the POWR Ratings now!